# Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL

> **NCT06151080** · PHASE2 · RECRUITING · sponsor: **The First Affiliated Hospital of Xiamen University** · enrollment: 38 (estimated)

## Conditions studied

- DLBCL - Diffuse Large B Cell Lymphoma
- Follicular Lymphoma

## Interventions

- **DRUG:** Lenalidomide combined with G-CHOP (LO CHOP)

## Key facts

- **NCT ID:** NCT06151080
- **Lead sponsor:** The First Affiliated Hospital of Xiamen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-22
- **Primary completion:** 2027-08-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2025-02-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06151080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06151080, "Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06151080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*